Cargando…

Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers

This study elucidated the clinical, humoral immune response and genomic analysis of vaccine breakthrough (VBT) infections after ChAdOx1 nCoV-19/Covishield vaccine in healthcare workers (HCWs). Amongst 1858 HCWs, 1639 had received either two doses (1346) or a single dose (293) of ChAdOx1 nCoV-19 vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kale, Pratibha, Gupta, Ekta, Bihari, Chhagan, Patel, Niharika, Rooge, Sheetalnath, Pandey, Amit, Bajpai, Meenu, Khillan, Vikas, Chattopadhyay, Partha, Devi, Priti, Maurya, Ranjeet, Jha, Neha, Mehta, Priyanka, Kumar, Manish, Sharma, Pooja, Saifi, Sheeba, Swaminathan, Aparna, Alam, Sarfaraz, Uppili, Bharathram, Faruq, Mohammed, Agrawal, Anurag, Pandey, Rajesh, Sarin, Shiv Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778656/ https://www.ncbi.nlm.nih.gov/pubmed/35062715 http://dx.doi.org/10.3390/vaccines10010054

Ejemplares similares

Performance evaluation of automated chemiluminescence immunoassay based antigen detection – Moving towards more reliable ways to predict SARS-CoV-2 infection
por: Paul, Diptanu, et al.
Publicado: (2021)

Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples
por: Gupta, Akshita, et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Chauhan, Anil, et al.
Publicado: (2020)

Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome
por: Maras, Jaswinder Singh, et al.
Publicado: (2021)

Acute hemorrhagic leukoencephalitis after administration of the first dose of ChAdOx1 nCoV-19 SARS-CoV-2 (COVISHIELD™) vaccine
por: Rizvi, Imran, et al.
Publicado: (2022)

Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients’ Clinical Sub-Phenotype
por: Mehta, Priyanka, et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Lodge, Archie
Publicado: (2020)

Post ChAdOx1 nCoV-19 vaccination frontal lobe syndrome
por: Tapdia, Madhusudan, et al.
Publicado: (2022)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
por: Voysey, Merryn, et al.
Publicado: (2020)

SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?
por: Saifi, Sheeba, et al.
Publicado: (2022)

Depression following ChAdOx1-S/nCoV-19 vaccine
por: Uvais, N.A.
Publicado: (2022)

Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination
por: Suri, Vinit, et al.
Publicado: (2021)

Integrated genomic view of SARS-CoV-2 in India
por: Kumar, Pramod, et al.
Publicado: (2020)

Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination
por: Kwon, Hyeryung, et al.
Publicado: (2021)

Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination
por: Spataro, Rossella, et al.
Publicado: (2022)

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
por: Schultz, Nina H., et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs
por: Maurya, Ranjeet, et al.
Publicado: (2023)

BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes
por: Abdul-Jawad, Sultan, et al.
Publicado: (2022)

Rapidly Progressive Dementia with Asymmetric Rigidity Following ChAdOx1 nCoV-19 Vaccination
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2022)

A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples
por: Madan, Taruna, et al.
Publicado: (2021)

Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients
por: Vaishya, Raju, et al.
Publicado: (2021)

Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2
por: Abdelhafiz, Ahmed Samir, et al.
Publicado: (2022)

Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
por: Rogawski McQuade, Elizabeth T, et al.
Publicado: (2021)

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
por: Normark, Johan, et al.
Publicado: (2021)

Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination
por: Crane, Phillip, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine
por: Lee, Hui Ping, et al.
Publicado: (2021)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
por: Ogbe, Ane, et al.
Publicado: (2022)

Autonomic dysfunction post-inoculation with ChAdOx1 nCoV-19 vaccine
por: Karimi Galougahi, Keyvan
Publicado: (2021)

Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine
por: Ahmer, Sadaf, et al.
Publicado: (2022)

Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies
por: Thookhamme, Chayapa, et al.
Publicado: (2023)

Determinants of COVID-19 Breakthrough Infections and Severity in ChAdOx1 nCoV-19–Vaccinated Priority Groups
por: Kaur, Upinder, et al.
Publicado: (2022)

Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal
por: Rayamajhi, Sushil, et al.
Publicado: (2022)

Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2
por: Anupama, Y.J., et al.
Publicado: (2021)

Geographical distribution of TTS cases following AZD1222 (ChAdOx1 nCoV-19) vaccination
por: Soboleva, Karina, et al.
Publicado: (2022)

ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review
por: Prabhahar, Arun, et al.
Publicado: (2022)

Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
por: Sheng, Wang-Huei, et al.
Publicado: (2022)

SARS-CoV-2 Mutations and COVID-19 Clinical Outcome: Mutation Global Frequency Dynamics and Structural Modulation Hold the Key
por: Maurya, Ranjeet, et al.
Publicado: (2022)

Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
por: Kakkassery, Helen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jr2rk83cuj2kr9vjb7p06qdqg2